Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only
$350.00
24 in stock (can be backordered)
Ships today if ordered and paid by 12 PM EST. (Except Saturdays & Sundays)
Due to our rigorous quality control standards and the fragile nature of our products, we cannot accept returns. In the rare occasion that your order arrives with missing, incorrect or damaged items, please email [email protected] for assistance. Our customer support representatives are standing by to ensure that our customers are 100% satisfied with our product quality, customer support and delivery. Cancellations must be requested by email before the order shipment has shipped. Once the order has shipped you may not cancel your order. Please contact us at [email protected] with any questions or concerns that you may have regarding your order. We will do our absolute best to assist you as quickly and satisfactorily as possible.Thank you.
GLP-3 (RTA) 40mg delivers a concentrated preparation of this triple incretin receptor agonist analog, specifically configured for extended pharmacokinetic profiling and sustained receptor occupancy studies in preclinical models. Supplied as lyophilized powder in a 40mg vial.
Compound Information:
• Research Name: GLP-3 (RTA) — Retatrutide Analog
• Receptor Targets: GLP-1R, GIPR, GCGR (triple agonist)
• Molecular Class: Synthetic multi-receptor incretin peptide analog
• Purity: ≥98% (HPLC verified)
GLP-3 (RTA) engages three distinct incretin-related receptors simultaneously, providing researchers with a unique pharmacological tool for studying coordinated receptor crosstalk and downstream second-messenger integration across metabolically active tissues in animal models.
Research Applications:
• Extended-duration receptor occupancy profiling across GLP-1R, GIPR, and GCGR in rodent tissue preparations
• Comparative pharmacokinetic analysis of sustained triple-agonist exposure versus sequential single-receptor activation
• Assessment of cAMP accumulation kinetics under prolonged multi-receptor stimulation conditions
• Investigation of receptor desensitization thresholds following extended triple-agonist administration in hepatic and pancreatic tissue
• Evaluation of differential signaling bias across receptor subtypes during chronic exposure protocols
Storage and Handling:
• Store sealed at -20°C in a desiccated environment away from light
• Reconstitute with bacteriostatic water immediately before experimental use
• Avoid repeated freeze-thaw cycles to maintain peptide integrity
• Use within 30 days of reconstitution when stored at 2-8°C
Product Specifications:
• Purity: ≥98%
• Appearance: White to off-white lyophilized powder
• Form: Lyophilized powder
• Quantity: 40mg per vial
FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.